Literature DB >> 6603659

Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs.

M Essex, M F McLane, T H Lee, N Tachibana, J I Mullins, J Kreiss, C K Kasper, M C Poon, A Landay, S F Stein, D P Francis, C Cabradilla, D N Lawrence, B L Evatt.   

Abstract

Along with homosexual men, Haitians, and intravenous drug abusers, hemophiliacs are at high risk of contracting acquired immunodeficiency syndrome (AIDS). An earlier study revealed that 36 percent of a group of the AIDS patients had antibodies to cell membrane antigens associated with the human T-cell leukemia virus (HTLV-MA), whereas only 1.2 percent of matched asymptomatic homosexual controls had these antibodies. In the present experiments, serum samples from 172 asymptomatic hemophiliacs were examined for the presence of antibodies to HTLV-MA. Such antibodies were detected in 5 to 19 percent of the hemophiliacs examined from four geographical locations, but in only 1 percent or less of laboratory workers, normal blood donors, donors on hemodialysis, or donors with chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603659     DOI: 10.1126/science.6603659

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  Practical diagnostic testing for human immunodeficiency virus.

Authors:  J B Jackson; H H Balfour
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 2.  Characterization of the acquired immune deficiency syndrome at the cellular and molecular level.

Authors:  D J Barrett
Journal:  Mol Cell Biochem       Date:  1984-08       Impact factor: 3.396

3.  Alterations of the lymphocyte subpopulations in haemophilia patients from Venezuela.

Authors:  F Merino; J W Medina; C Amesty; L De Salvo
Journal:  Blut       Date:  1984-10

4.  Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany.

Authors:  G Hunsmann; J Schneider; H Bayer; H Berthold; K Schimpf; H Kabisch; K Ritter; U Bienzle; H Schmitz; P Kern
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

Review 5.  Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up.

Authors:  Shinichi Oka; Kazuko Ikeda; Misao Takano; Miwa Ogane; Junko Tanuma; Kunihisa Tsukada; Hiroyuki Gatanaga
Journal:  Glob Health Med       Date:  2020-02-29

Review 6.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research.

Authors:  Mark A Beilke
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02       Impact factor: 2.205

7.  Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection.

Authors:  T H Lee; J E Coligan; T Homma; M F McLane; N Tachibana; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus.

Authors:  T H Lee; J E Coligan; M F McLane; J G Sodroski; M Popovic; F Wong-Staal; R C Gallo; W Haseltine; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Expression of HTLV-specific polypeptides in various human T-cell lines.

Authors:  Y Koyanagi; Y Hinuma; J Schneider; T Chosa; G Hunsmann; N Kobayashi; M Hatanaka; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

10.  Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease.

Authors:  L J Levitt; G R Reyes; D K Moonka; K Bensch; R A Miller; E G Engleman
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.